ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................*JBDM Ver 2.0.16 (1th of February 2022) - 2999001/03107548CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120220720W173deBibliographieenBibliographyfrBibliographieEP15752250.9201502202016081920180504enenen201461942545 P20140220US201462031811 P20140731US2022072020222920161228201652202206082022232022010420220720202229A61K 31/616 20060101AFI20170913BHEP A61K 31/616 20130101 FI20150917BHEP A61K 9/0075 20130101 LI20160128BHEP A61K 31/4365 20130101 LI20160128BHEP A61P 9/10 20180101 LI20200331BHEP deTROCKENPULVERFORMULIERUNGEN ZUR INHALATIONenDRY POWDER FORMULATIONS FOR INHALATIONfrPRÉPARATIONS DE POUDRE SÈCHE À INHALERUS-A1- 2008 044 481US-A1- 2008 306 033US-A1- 2010 258 118US-A1- 2014 322 328US-B2- 6 979 437HADINOTO ET AL: "Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER, AMSTERDAM, NL, vol. 341, no. 1-2, 24 July 2007 (2007-07-24), pages 195-206, XP022166304, ISSN: 0378-5173, DOI: 10.1016/J.IJPHARM.2007.03.035H.J.M. BARNETT; M. KASTE; H.MELDRUM; M. ELIASZIW: "Aspirin dose in stroke prevention", STROKE, vol. 27, 31 December 1996 (1996-12-31), pages 588-592,2017091922176400.420220531YADIDI, Kambiz717 Lakefield Road DWestlake Village, California 91361USOtitopic Inc.101949760B2300EPPC120 Park AvenueNew York, NY 10017USEllis, Robin Patrick101845933Reddie & Grose LLP The White Chapel Building 10 Whitechapel High StreetLondon E1 8QSGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRUS201501696920150220enWO201512731520150827201534